Fayetteville pharmaceutical development firm BiologicsMD has named David Owens its first CEO.
BiologicsMD is a portfolio company of VIC Technology Venture Development, which had previously managed its operations.
Most recently, Owens was chief business officer for Novira Therapeutics, an antiviral drug discovery company based in Doylestown, Pa. In March, Novira completed a $25 million Series A financing round.
BiologicsMD has developed an osteoporosis treatment, PTH-CBD, that binds to the bone and stimulates new bone growth.
“I’m very excited to join the BiologicsMD team at this very important stage in advancing the company’s lead development drug, PTH-CBD, towards the clinic,” Owens said in a news release. Continue reading
Movista co-founders Stan Zylowski and April Seggebrush (Photo by Beth Hall)
Bentonville retail software firm Movista has received an $82,959 investment from the Arkansas Science & Technology Authority.
The funds will be used to commercialize Movista’s proprietary technology, which provides retail tracking, verifying and reporting activities, according to a news release. The funds will come from ASTA’s Seed Capital Investment Program.
Movista is an Innovate Arkansas client firm. ASTA recently invested in another IA company, Angel Eye Camera Systems of Little Rock. Continue reading
University of Arkansas startup Picasolar, which developed a way to make solar cells more efficient, tied for second at the National Clean Energy Business Plan Competition this week in Washington, D.C.
The event, in its second year, is put on by the U.S. Department of Energy and brings together six regional winners from across the country. Winners were announced on Tuesday, and SiNode Systems from Northwestern University was the overall winner. Continue reading
Fayetteville drug development startup BiologicsMD announced on Tuesday a partnership with an Oklahoma firm that will make the company’s osteoporosis treatment.
BioMD, which has developed what it considers a breakthrough treatment for the disease called PTH-CBD, has contracted with Cytovance Biologics of Oklahoma City to develop a manufacturing platform for the drug.
In addition, the firm has welcomed its newest board member, Ensysce Biosciences CEO Lynn Kirkpatrick, to help guide it through the Food and Drug Administration approval process. Continue reading
University of Arkansas startup HomeDx won the elevator pitch portion and finished second overall in the graduate-level division of the 2013 Donald W. Reynolds Tri-State Governor’s Cup business-plan competition Tuesday in Las Vegas.
Four Arkansas teams — the top two winners in the undergraduate and graduate divisions of the Arkansas DWR Governor’s Cup – competed against the top winners from Oklahoma and Nevada. Teams from Oklahoma State University and the University of Oklahoma took home top honors. Continue reading
University of Arkansas’s HomeDx Team Wins Graduate Elevator Pitch Contest, Places 2nd in Competition
The Arkansas Economic Acceleration Foundation, an affiliate of The Arkansas Capital Corporation Group, is pleased to announce that R2R Technologies of Oklahoma State University of Stillwater, Okla., and Field Focus of Oklahoma State University of Norman, Okla., are the 2013 winners of the Donald W. Reynolds Tri-State Award in Las Vegas.
First place winners took home a $30,000 cash prize, a team trophy and individual plaques. The second place winners received $20,000 prize, a trophy and individual plaques. The teams’ faculty advisors earned a $3,500 check as well.
“I am extremely impressed by the sophistication of the business plans this year,” said C. Sam Walls, chief executive officer of the Arkansas Capital Corporation and chairman of The Arkansas Economic Acceleration Foundation. “These students represent Arkansas’s economic future, and the entrepreneurial skills they have gained are invaluable.”